U6 small nuclear RNA pseudogene 125 (RNU6-125P)

**U6 small nuclear RNA pseudogene 125 (RNU6-125P)** is a genomic DNA element derived from the U6 snRNA gene, part of the family of small nuclear RNA pseudogenes commonly found in vertebrate genomes[5]. U6 snRNA itself is a uridine-rich, highly conserved non-coding RNA essential for spliceosome function and pre-mRNA splicing in the nucleus[1][2][5]. The RNU6-125P locus, like other snRNA pseudogenes, is noncoding and does not encode a functional product; it is considered a **pseudogene** rather than an actionable therapeutic target, receptor, or enzyme[1][5]. Pseudogenes like RNU6-125P can arise via mechanisms such as retrotransposition, often involving chimeric events with elements like LINE-1, but generally lack biological activity and are not involved in disease processes or drug interactions[1]. There is no evidence for roles in signaling, cell cycle regulation, disease, or use as biomarkers or drug targets. RNU6-125P is a pseudogene representing a genomic copy of U6 snRNA that is non-functional, not a drug target, not involved in disease, and not used as a biomarker[1][5]. The correct molecular classification is *pseudogene*, and entries describing it as a target are incorrect. The use of "RNA, U6 small nuclear 125, pseudogene" as a drug discovery or therapeutic target is incorrect. Pseudogenes, including RNU6-125P, are generally non-functional remnants of ancestral functional genes and are not classified amongst receptors, enzymes, or traditional drug targets[1][5]. Pseudogenes, by definition, do not encode proteins or functional RNAs with actionable roles.

Other names

RNU6-125PRNA, U6 small nuclear 125, pseudogene